Biosynthetic origins of the large macrolide, oligomycin ABÚ'LOCK, J. D; MORRIS, G. A; RICHARDS, M. K et al.Tetrahedron letters. 1986, Vol 27, Num 25, pp 2917-2920, issn 0040-4039Article

Pharmacopœial procedure for the determination of tylosin factors by high-performance liquid chromatographyFISH, B. J; CARR, G. P. R.Journal of chromatography. 1986, Vol 353, pp 39-50, issn 0021-9673Conference Paper

Fotometrische Bestimmung des Makrolid-Antibioticums Turimycin = Détermination photométrique de l'antibiotique macrolide turimycine = Photometric determination of the macrolide antibiotic turimycineHESSE, G.Pharmazie. 1984, Vol 39, Num 11, pp 775-776, issn 0031-7144Article

Macrolide biosynthesis: sterochemistry of the hydroxylation of brefeldin CGONZALEZ DE LA PARRA, M; HUTCHINSON, C. R.Journal of antibiotics (Tokyo. 1968). 1987, Vol 40, Num 8, pp 1170-1174, issn 0021-8820Article

Resistance to erythromycinFERNANDES, P. B; GARMAISE, D.Journal of antimicrobial chemotherapy (Print). 1987, Vol 20, Num 3, pp 449-450, issn 0305-7453Article

Stereocontrolled first total synthesis of mycinolide IVSUZUKI, K; MATSUMOTO, T; TOMOOKA, K et al.Chemistry Letters. 1987, Num 1, pp 113-116, issn 0366-7022Article

Synthetic studies of the nargenicins. II: Synthesis of the northern half of nargenicin A₁KALLMERTEN, J; PLATA, D. J.Heterocycles (Sendai). 1987, Vol 25, pp 145-149, issn 0385-5414, no. spécArticle

Erythromycin and cyclosporineGONWA, T. A; NGHIEM, D. D; SCHULAK, J. A et al.Transplantation. 1986, Vol 41, Num 6, pp 797-799, issn 0041-1337Article

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (second of two parts)WASHINGTON, J. A. II; WILSON, W. R.Mayo Clinic proceedings. 1985, Vol 60, Num 4, pp 271-278, issn 0025-6196Article

Alternate interpretation of the role of water in the erythromycin structureBAUER, J; QUICK, J; OHEIM, R et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 8, pp 899-900, issn 0022-3549Article

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (first of two parts)WASHINGTON, J. A. II; WILSON, W. R.Mayo Clinic proceedings. 1985, Vol 60, Num 3, pp 189-203, issn 0025-6196Article

Vermiculine, a metabolic product from Talaromyces wortmanniiJONES, D; ANDERSON, H. A; RUSSELL, J. D et al.Transactions of the British Mycological Society. 1984, Vol 83, Num 4, pp 718-721, issn 0007-1536Article

Intrazelluläre Wirkung von Josamycin = Action intracellulaire de la josamycine = Intracellular action of JosamycinWILDFEUER, A; LAUFEN, H; GALLE, J et al.Arzneimittel-Forschung. 1986, Vol 36, Num 1, pp 127-131, issn 0004-4172Article

Structure of a new macrolide antibiotic, X-14952BOMURA, S; NAKAGAWA, A; IMAMURA, N et al.Journal of antibiotics (Tokyo. 1968). 1985, Vol 38, Num 5, pp 674-676, issn 0021-8820Article

Enzymatic phosphorylation of macrolide antibioticsWILEY, P. F; BACZYNSKYJ, L; DOLAK, L. A et al.Journal of antibiotics (Tokyo. 1968). 1987, Vol 40, Num 2, pp 195-201, issn 0021-8820Article

Chiral synthesis of polyketide-derived natural products. III: Stereocontrolled synthesis of a chiral fragment corresponding to both the C-1―C-4 and C-9―C-12 units of erythromycin A from D-glucoseOIKAWA, Y; NISHI, T; YONEMITSU, O et al.Journal of the Chemical Society. Perkin transactions. I. 1985, Num 1, pp 1-5, issn 0300-922XArticle

Determination of the activity on Legionella of eight macrolides and related agents by comparative testing on three mediaBORNSTEIN, N; ROUDIER, C; FLEURETTE, J et al.Journal of antimicrobial chemotherapy (Print). 1985, Vol 15, Num 1, pp 17-22, issn 0305-7453Article

Atteinte hépatique induite par le propionate d'érythromycine = Liver damage induced by erythromycine propionateSIMON, C; ROUL, G; CHABRIER, G et al.La Revue de médecine interne (Paris). 1985, Vol 6, Num 1, pp 84-85, issn 0248-8663Article

Biosynthesis of macrolide antibiotics. VI: Late steps in brefeldin A biosynthesisYAMAMOTO, Y; HORI, A; HUTCHINSON, C. R et al.Journal of the American Chemical Society. 1985, Vol 107, Num 8, pp 2471-2474, issn 0002-7863Article

Influence of bariatric surgery on erythromycin absorptionPRINCE, R. A; PINCHEIRA, J. C; MASON, E. E et al.Journal of clinical pharmacology. 1984, Vol 24, Num 11-12, pp 523-527, issn 0091-2700Article

Potassium wasting and other renal tubular defects with rifampin nephrotoxicityJEN-TSE CHENG; KAHN, T.American journal of nephrology. 1984, Vol 4, Num 6, pp 379-382, issn 0250-8095Article

Pemphigus foliaceus induced by rifampicinLEE, C. W; LIM, J. H; KANG, H. J et al.British journal of dermatology (1951). 1984, Vol 111, Num 5, pp 619-622, issn 0007-0963Article

The influence of rifampin on quinidine and digoxinBUSSEY, H. I; MERRITT, G. J; HILL, E. G et al.Archives of internal medicine (1960). 1984, Vol 144, Num 5, pp 1021-1023, issn 0003-9926Article

Evaluation of the immunostimulating activity of erythromycin in manFRASCHINI, F; SCAGLIONE, F; FERRARA, F et al.Chemotherapy (Basel). 1986, Vol 32, Num 3, pp 286-290, issn 0009-3157Article

The structure of a novel macrolide antibiotic, notonesomycin ASASAKI, T; FURIHATA, K; NAKAYAMA, H et al.Tetrahedron letters. 1986, Vol 27, Num 14, pp 1603-1606, issn 0040-4039Article